Summary
This 2023 synthesis in Cell Metabolism presents a comprehensive epidemiological analysis of the global burden of metabolic diseases, drawing on global health datasets to quantify regional variation and temporal trends across two decades. The work documents the scale of non-communicable disease burden attributable to obesity, diabetes, and related metabolic dysfunction, providing essential context for understanding how dietary patterns and food systems intersect with population health outcomes. The analysis underscores metabolic disease as a major driver of global morbidity and mortality, though the paper is epidemiological rather than examining direct causal linkages to specific food systems or farming practices.
Regional applicability
As a global epidemiological synthesis, this study provides context relevant to United Kingdom public health and policy, where metabolic disease burden is substantial. Findings on regional variation and trends may inform UK strategies for non-communicable disease prevention and dietary policy, though country-specific data disaggregation would be needed to quantify UK-specific burden.
Key measures
Regional variation and temporal trends in metabolic disease burden; morbidity and mortality attributable to obesity, diabetes, and metabolic dysfunction
Outcomes reported
The study quantified regional variation and temporal trends in the global burden of metabolic diseases (obesity, diabetes, and related metabolic dysfunction) across two decades (2000–2019). It documented morbidity and mortality attributable to these conditions at global and regional scales.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.